US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ensysce Biosciences Inc.

0.4580

+0.02866.66%

Post-market: 0.47120.0132+2.88%19:49 EDT

Volume:1.26M

Turnover:563.14K

Market Cap:8.91M

PE:-0.17

High:0.4743

Open:0.4390

Low:0.4014

Close:0.4294

52wk High:2.75

52wk Low:0.2300

Shares:19.46M

Float Shares:18.38M

Volume Ratio:3.68

T/O Rate:6.87%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7523

EPS(LYR):-3.9790

ROE:-1295.09%

ROA:-185.51%

PB:-11.40

PE(LYR):-0.12

Loading ...

Overview Company News Filings

Ensysce Biosciences enrolls first patient in final stage of PF614-MPAR-102

Ensysce Enrolls First Patient in Final Phase of Pf614-mpar-102 Overdose-protection Trial

Ensysce Biosciences Files for Sale of 1.3 Million Shares

MT Newswires Live

Ensysce Biosciences files to sell 1.3M shares of common stock for holders

Ensysce Biosciences faces Nasdaq delisting risk over $2.5 million equity shortfall

Ensysce Biosciences posts investor presentation on trypsin-controlled opioids with abuse, overdose protection

Ensysce Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

BRIEF-Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing

Ensysce Biosciences Inc - Launches Formal Review of Strategic Alternatives - SEC Filing

THOMSON REUTERS

Ensysce Biosciences Q1 EPS $(0.52) Beats $(0.73) Estimate, Sales $960.999K Miss $1.900M Estimate

Benzinga Earnings

Ensysce Q1 FY26 net loss widens to $3.6 million

Ensysce announces expansion of patent protection for MPAR technology

Ensysce says Taiwan grants MPAR overdose-protection patent through 2042

Top Premarket Gainers

MT Newswires Live

Ensysce Biosciences Inc expected to post a loss of 73 cents a share - Earnings Preview

Ensysce CEO speaks at Pain Therapeutics Summit Europe in Amsterdam

Ensysce Biosciences posts investor presentation on TAAP, MPAR opioid pain programs

Ensysce secures IRB approval of final phase of PF614-MPAR-102 study

Ensysce gets IRB clearance to start final phase of PF614-MPAR-102 study

Ensysce Biosciences files to sell 20.34M shares of common stock for holders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ENSC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENSC\",,,,,undefined,":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":0.458,"timestamp":1791489600000,"preClose":0.4294,"halted":0,"volume":1263061,"hourTrading":{"tag":"盘后","latestPrice":0.4712,"preClose":0.458,"latestTime":"19:49 EDT","volume":35706,"amount":15858.200864,"timestamp":1791503369859,"change":0.0132,"changeRate":0.028821,"amplitude":0.065502},"delay":0,"changeRate":0.06660456450861671,"floatShares":18378990,"shares":19456800,"eps":-2.7523,"marketStatus":"Closed","change":0.0286,"latestTime":"10-08 16:00:00 EDT","open":0.439,"high":0.4743,"low":0.4014,"amount":563139.71286154,"amplitude":0.169772,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.7523,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4294,"preHourTrading":{"tag":"盘前","latestPrice":0.44,"preClose":0.4294,"latestTime":"09:08 EDT","volume":1935,"amount":827.1785601,"timestamp":1791464931813,"change":0.0106,"changeRate":0.024686,"amplitude":0.11551},"postHourTrading":{"tag":"盘后","latestPrice":0.4712,"preClose":0.458,"latestTime":"19:49 EDT","volume":35706,"amount":15858.200864,"timestamp":1791503369859,"change":0.0132,"changeRate":0.028821,"amplitude":0.065502},"volumeRatio":3.678556,"impliedVol":3.1521,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENSC\",,,,,undefined,":{"symbol":"ENSC","floatShares":18378990,"roa":"-185.51%","roe":"-1295.09%","lyrEps":-3.978959,"volumeRatio":3.678556,"shares":19456800,"dividePrice":0,"high":0.4743,"amplitude":0.169772,"preClose":0.4294,"low":0.4014,"week52Low":0.23,"pbRate":"-11.40","psRate":"1.98","week52High":2.75,"institutionHeld":0,"latestPrice":0.458,"eps":-2.7523,"divideRate":0,"volume":1263061,"delay":0,"ttmEps":-2.7523,"open":0.439,"prevYearClose":0.92,"prevWeekClose":0.395,"prevMonthClose":0.4158,"prevQuarterClose":0.4158,"fiveDayClose":0.3998,"twentyDayClose":0.5159,"sixtyDayClose":0.2914},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENSC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ENSC","fiscalQuarterEnding":"2026/06","expectedEps":-0.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2026-05-15","symbol":"ENSC","fiscalQuarterEnding":"2026/03","expectedEps":-0.73,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2026-03-30","symbol":"ENSC","fiscalQuarterEnding":"2025/12","expectedEps":-1.26,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2025-11-14","symbol":"ENSC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-13","symbol":"ENSC","fiscalQuarterEnding":"2025/06","expectedEps":-1.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENSC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENSC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENSC","date":"2026-10-07","current":-0.166406,"percent":0.306623,"low":-611.547874,"twenty":-0.938128,"median":-0.405593,"eighty":-0.228907,"high":-0.089484,"avg":-13.196196,"sd":83.551035,"marketCap":8362530},"quantilePoints":[{"date":"2021-10-08","current":-582.075678,"twenty":-800.661067,"median":-611.547874,"eighty":1000.40781,"marketCap":57485794},{"date":"2021-10-15","current":-582.075678,"twenty":-788.380994,"median":-604.17982,"eighty":986.317559,"marketCap":57485794},{"date":"2021-10-22","current":-547.691464,"twenty":-781.01294,"median":-601.723805,"eighty":986.303472,"marketCap":54090009},{"date":"2021-10-29","current":-540.32342,"twenty":-780.52174,"median":-596.811776,"eighty":885.234099,"marketCap":53362341},{"date":"2021-11-05","current":-552.603493,"twenty":-778.556926,"median":-582.075678,"eighty":880.640679,"marketCap":54575121},{"date":"2021-11-12","current":-542.779435,"twenty":-776.100911,"median":-575.935642,"eighty":879.231656,"marketCap":53604897},{"date":"2021-11-19","current":-2.041392,"twenty":-776.100911,"median":-559.971547,"eighty":796.099172,"marketCap":38445141},{"date":"2021-11-26","current":-2.034952,"twenty":-774.1361,"median":-555.059508,"eighty":785.954194,"marketCap":38323863},{"date":"2021-12-03","current":-1.609931,"twenty":-769.715274,"median":-550.147479,"eighty":769.891308,"marketCap":30319512},{"date":"2021-12-10","current":-5.705594,"twenty":-764.803244,"median":-542.779435,"eighty":694.367562,"marketCap":107452350},{"date":"2021-12-17","current":-3.812316,"twenty":-763.820838,"median":-539.095413,"eighty":648.151541,"marketCap":71796604},{"date":"2021-12-23","current":-6.594276,"twenty":-762.34723,"median":-537.867406,"eighty":615.743964,"marketCap":124188721},{"date":"2021-12-31","current":-6.053339,"twenty":-758.417601,"median":-6.594276,"eighty":588.690681,"marketCap":114001365},{"date":"2022-01-07","current":-5.138899,"twenty":-754.979176,"median":-6.175695,"eighty":578.5457,"marketCap":96779882},{"date":"2022-01-14","current":-4.224458,"twenty":-753.99677,"median":-5.705594,"eighty":551.774222,"marketCap":79558399},{"date":"2022-01-21","current":-3.078187,"twenty":-753.99677,"median":-5.692715,"eighty":524.720941,"marketCap":57970907},{"date":"2022-01-28","current":-2.150867,"twenty":-750.067147,"median":-5.409367,"eighty":500.767517,"marketCap":40506868},{"date":"2022-02-04","current":-2.073591,"twenty":-736.313461,"median":-5.254814,"eighty":478.223115,"marketCap":39051531},{"date":"2022-02-11","current":-2.073591,"twenty":-719.612556,"median":-4.939267,"eighty":276.652164,"marketCap":39051531},{"date":"2022-02-18","current":-1.39742,"twenty":-709.29729,"median":-4.623721,"eighty":-1.482424,"marketCap":26317336},{"date":"2022-02-25","current":-1.40386,"twenty":-687.68435,"median":-4.456288,"eighty":-1.367797,"marketCap":26438614},{"date":"2022-03-04","current":-1.378101,"twenty":-617.442308,"median":-4.218019,"eighty":-1.378101,"marketCap":25953502},{"date":"2022-03-11","current":-1.416739,"twenty":-611.056671,"median":-4.17294,"eighty":-1.367797,"marketCap":26681170},{"date":"2022-03-18","current":-1.584172,"twenty":-608.600654,"median":-3.915351,"eighty":-1.367797,"marketCap":29834399},{"date":"2022-03-25","current":-1.455377,"twenty":-606.635834,"median":-3.72216,"eighty":-1.378101,"marketCap":27408838},{"date":"2022-04-01","current":-0.909052,"twenty":-605.653428,"median":-3.026669,"eighty":-1.367797,"marketCap":26438614},{"date":"2022-04-08","current":-0.942412,"twenty":-601.723805,"median":-2.640286,"eighty":-1.243923,"marketCap":27408838},{"date":"2022-04-14","current":-0.892372,"twenty":-601.723805,"median":-2.31186,"eighty":-1.109211,"marketCap":25953502},{"date":"2022-04-22","current":-0.884033,"twenty":-599.267791,"median":-2.221704,"eighty":-0.942412,"marketCap":25710946},{"date":"2022-04-29","current":-0.917392,"twenty":-599.267791,"median":-2.189506,"eighty":-0.917392,"marketCap":26681170},{"date":"2022-05-06","current":-0.935552,"twenty":-594.355761,"median":-2.131548,"eighty":-0.917392,"marketCap":27209326},{"date":"2022-05-13","current":-0.797005,"twenty":-582.075678,"median":-2.08647,"eighty":-0.892372,"marketCap":23214444},{"date":"2022-05-20","current":-0.624837,"twenty":-582.075678,"median":-2.073591,"eighty":-0.867353,"marketCap":18199682},{"date":"2022-05-27","current":-0.62899,"twenty":-582.075678,"median":-2.041392,"eighty":-0.82967,"marketCap":18320644},{"date":"2022-06-03","current":-0.645958,"twenty":-578.146055,"median":-2.034952,"eighty":-0.778733,"marketCap":18814863},{"date":"2022-06-10","current":-0.587461,"twenty":-575.198838,"median":-1.960895,"eighty":-0.698325,"marketCap":17111019},{"date":"2022-06-17","current":-0.537744,"twenty":-566.848388,"median":-1.931917,"eighty":-0.663661,"marketCap":15662924},{"date":"2022-06-24","current":-0.547118,"twenty":-561.936359,"median":-1.803122,"eighty":-0.641971,"marketCap":15935954},{"date":"2022-07-01","current":-0.675147,"twenty":-559.971547,"median":-1.758044,"eighty":-0.628942,"marketCap":19665057},{"date":"2022-07-08","current":-0.740288,"twenty":-558.006731,"median":-1.63569,"eighty":-0.63179,"marketCap":21562441},{"date":"2022-07-15","current":-0.73318,"twenty":-554.077102,"median":-1.584172,"eighty":-0.639978,"marketCap":21355409},{"date":"2022-07-22","current":-0.750097,"twenty":-552.603493,"median":-1.526215,"eighty":-0.650372,"marketCap":21848142},{"date":"2022-07-29","current":-0.645214,"twenty":-550.638681,"median":-1.455377,"eighty":-0.648267,"marketCap":18793198},{"date":"2022-08-05","current":-0.542837,"twenty":-547.691464,"median":-1.436058,"eighty":-0.628919,"marketCap":15811251},{"date":"2022-08-12","current":-0.502219,"twenty":-545.726652,"median":-1.416739,"eighty":-0.623627,"marketCap":18104172},{"date":"2022-08-19","current":-0.4432,"twenty":-541.797029,"median":-1.400842,"eighty":-0.597747,"marketCap":15976634},{"date":"2022-08-26","current":-0.437558,"twenty":-540.32342,"median":-1.39098,"eighty":-0.585573,"marketCap":15773232},{"date":"2022-09-02","current":-0.436493,"twenty":-539.341014,"median":-1.39098,"eighty":-0.574176,"marketCap":15734855},{"date":"2022-09-09","current":-0.364844,"twenty":-537.867406,"median":-1.38776,"eighty":-0.560252,"marketCap":13152036},{"date":"2022-09-16","current":-0.333012,"twenty":-537.867406,"median":-1.378101,"eighty":-0.543432,"marketCap":12004543},{"date":"2022-09-23","current":-0.234109,"twenty":-537.376203,"median":-1.352342,"eighty":-0.508327,"marketCap":8439255},{"date":"2022-09-30","current":-0.228893,"twenty":-429.647968,"median":-1.243734,"eighty":-0.498322,"marketCap":8251204},{"date":"2022-10-07","current":-0.234216,"twenty":-6.555638,"median":-1.18844,"eighty":-0.457146,"marketCap":8443092},{"date":"2022-10-14","current":-0.220376,"twenty":-6.367598,"median":-1.109211,"eighty":-0.440474,"marketCap":7944182},{"date":"2022-10-21","current":-0.210262,"twenty":-6.210469,"median":-1.003086,"eighty":-0.435641,"marketCap":7579594},{"date":"2022-10-28","current":-0.250893,"twenty":-6.104857,"median":-0.950752,"eighty":-0.392333,"marketCap":9044283},{"date":"2022-11-04","current":-0.17653,"twenty":-5.98379,"median":-0.934812,"eighty":-0.354113,"marketCap":6363632},{"date":"2022-11-11","current":-0.1248,"twenty":-5.705594,"median":-0.917392,"eighty":-0.266963,"marketCap":4498831},{"date":"2022-11-18","current":-0.202801,"twenty":-5.703018,"median":-0.904882,"eighty":-0.252442,"marketCap":5824224},{"date":"2022-11-25","current":-0.338332,"twenty":-5.692715,"median":-0.892372,"eighty":-0.252314,"marketCap":9716511},{"date":"2022-12-02","current":-0.220875,"twenty":-5.666956,"median":-0.884033,"eighty":-0.252314,"marketCap":6343293},{"date":"2022-12-09","current":-0.218547,"twenty":-5.525282,"median":-0.867353,"eighty":-0.245714,"marketCap":6276429},{"date":"2022-12-16","current":-0.173271,"twenty":-5.293452,"median":-0.82967,"eighty":-0.238048,"marketCap":4976162},{"date":"2022-12-23","current":-0.160808,"twenty":-5.254814,"median":-0.801912,"eighty":-0.234216,"marketCap":4618230},{"date":"2022-12-30","current":-0.167485,"twenty":-5.254814,"median":-0.794791,"eighty":-0.233587,"marketCap":4809988},{"date":"2023-01-06","current":-0.162144,"twenty":-5.208448,"median":-0.777262,"eighty":-0.229014,"marketCap":4656609},{"date":"2023-01-13","current":-0.172083,"twenty":-5.154354,"median":-0.761172,"eighty":-0.22176,"marketCap":4942034},{"date":"2023-01-20","current":-0.151312,"twenty":-4.979194,"median":-0.754483,"eighty":-0.220248,"marketCap":4345527},{"date":"2023-01-27","current":-0.15636,"twenty":-4.713877,"median":-0.749721,"eighty":-0.212142,"marketCap":4490485},{"date":"2023-02-03","current":-0.285115,"twenty":-4.654632,"median":-0.740288,"eighty":-0.212142,"marketCap":8188175},{"date":"2023-02-10","current":-0.319777,"twenty":-4.577355,"median":-0.716973,"eighty":-0.2146,"marketCap":9183632},{"date":"2023-02-17","current":-0.306121,"twenty":-4.487199,"median":-0.704416,"eighty":-0.217004,"marketCap":8791464},{"date":"2023-02-24","current":-0.268404,"twenty":-4.453712,"median":-0.69164,"eighty":-0.21887,"marketCap":7708271},{"date":"2023-03-03","current":-0.278653,"twenty":-4.399619,"median":-0.674554,"eighty":-0.220206,"marketCap":8002622},{"date":"2023-03-10","current":-0.295605,"twenty":-4.221882,"median":-0.670756,"eighty":-0.220476,"marketCap":8489450},{"date":"2023-03-17","current":-0.319044,"twenty":-4.206427,"median":-0.666784,"eighty":-0.220988,"marketCap":9162596},{"date":"2023-03-24","current":-0.28195,"twenty":-4.183244,"median":-0.656993,"eighty":-0.221547,"marketCap":8097283},{"date":"2023-03-31","current":-0.251749,"twenty":-4.160061,"median":-0.645586,"eighty":-0.223101,"marketCap":6085356},{"date":"2023-04-06","current":-0.180809,"twenty":-4.108543,"median":-0.632491,"eighty":-0.22144,"marketCap":4370577},{"date":"2023-04-14","current":-0.203676,"twenty":-3.992628,"median":-0.624837,"eighty":-0.218547,"marketCap":4923327},{"date":"2023-04-21","current":-0.218035,"twenty":-3.838075,"median":-0.616531,"eighty":-0.218035,"marketCap":5270402},{"date":"2023-04-28","current":-0.207399,"twenty":-3.812316,"median":-0.595341,"eighty":-0.211114,"marketCap":5013309},{"date":"2023-05-05","current":-0.186,"twenty":-3.72216,"median":-0.589774,"eighty":-0.207399,"marketCap":4496040},{"date":"2023-05-12","current":-0.170057,"twenty":-3.593365,"median":-0.578926,"eighty":-0.203676,"marketCap":4110665},{"date":"2023-05-19","current":-0.138524,"twenty":-3.078187,"median":-0.574237,"eighty":-0.198975,"marketCap":3519757},{"date":"2023-05-26","current":-0.119818,"twenty":-2.975152,"median":-0.564854,"eighty":-0.195168,"marketCap":3044461},{"date":"2023-06-02","current":-0.12184,"twenty":-2.799991,"median":-0.554475,"eighty":-0.191738,"marketCap":3095845},{"date":"2023-06-09","current":-0.11729,"twenty":-2.663469,"median":-0.544325,"eighty":-0.188162,"marketCap":2980232},{"date":"2023-06-16","current":-0.120324,"twenty":-2.403304,"median":-0.537744,"eighty":-0.185529,"marketCap":3057307},{"date":"2023-06-22","current":-0.110212,"twenty":-2.331179,"median":-0.512831,"eighty":-0.181667,"marketCap":2800390},{"date":"2023-06-30","current":-0.089484,"twenty":-2.31186,"median":-0.504284,"eighty":-0.180301,"marketCap":2273711},{"date":"2023-07-07","current":-0.108696,"twenty":-2.269358,"median":-0.500344,"eighty":-0.179074,"marketCap":2761853},{"date":"2023-07-14","current":-0.095551,"twenty":-2.235871,"median":-0.48602,"eighty":-0.176463,"marketCap":2427861},{"date":"2023-07-21","current":-0.228917,"twenty":-2.222992,"median":-0.463108,"eighty":-0.17453,"marketCap":5816563},{"date":"2023-07-28","current":-0.230007,"twenty":-2.204961,"median":-0.448416,"eighty":-0.176463,"marketCap":5844261},{"date":"2023-08-04","current":-0.212566,"twenty":-2.189506,"median":-0.439793,"eighty":-0.177048,"marketCap":5401094},{"date":"2023-08-11","current":-0.213656,"twenty":-2.17405,"median":-0.436546,"eighty":-0.178163,"marketCap":5428792},{"date":"2023-08-18","current":-0.284273,"twenty":-2.145715,"median":-0.431596,"eighty":-0.17894,"marketCap":5612832},{"date":"2023-08-25","current":-0.281373,"twenty":-2.132836,"median":-0.405938,"eighty":-0.179667,"marketCap":5555558},{"date":"2023-09-01","current":-0.268319,"twenty":-2.119956,"median":-0.373875,"eighty":-0.180213,"marketCap":5297826},{"date":"2023-09-08","current":-0.274121,"twenty":-2.107077,"median":-0.367186,"eighty":-0.180403,"marketCap":5412374},{"date":"2023-09-15","current":-0.255266,"twenty":-2.08647,"median":-0.356221,"eighty":-0.180828,"marketCap":5040094},{"date":"2023-09-22","current":-0.23061,"twenty":-2.083894,"median":-0.35054,"eighty":-0.181286,"marketCap":4553267},{"date":"2023-09-29","current":-0.197251,"twenty":-2.073591,"median":-0.336589,"eighty":-0.182977,"marketCap":3894618},{"date":"2023-10-06","current":-0.159541,"twenty":-2.068439,"median":-0.324381,"eighty":-0.181273,"marketCap":3150059},{"date":"2023-10-12","current":-0.175495,"twenty":-2.047832,"median":-0.319777,"eighty":-0.180154,"marketCap":3465064},{"date":"2023-10-20","current":-0.224808,"twenty":-2.041392,"median":-0.319097,"eighty":-0.180301,"marketCap":4438719},{"date":"2023-10-27","current":-0.15519,"twenty":-2.038816,"median":-0.31805,"eighty":-0.180213,"marketCap":3064148},{"date":"2023-11-03","current":-0.147166,"twenty":-2.034952,"median":-0.312913,"eighty":-0.177994,"marketCap":2905715},{"date":"2023-11-10","current":-0.135455,"twenty":-2.034952,"median":-0.311621,"eighty":-0.175524,"marketCap":2674479},{"date":"2023-11-17","current":-0.234708,"twenty":-2.022073,"median":-0.305807,"eighty":-0.175796,"marketCap":2957311},{"date":"2023-11-24","current":-0.219726,"twenty":-1.970555,"median":-0.300549,"eighty":-0.176418,"marketCap":2768546},{"date":"2023-12-01","current":-0.284645,"twenty":-1.951236,"median":-0.295186,"eighty":-0.17653,"marketCap":3586526},{"date":"2023-12-08","current":-0.245519,"twenty":-1.931917,"median":-0.292717,"eighty":-0.177824,"marketCap":3093536},{"date":"2023-12-15","current":-0.25718,"twenty":-1.931917,"median":-0.287495,"eighty":-0.178672,"marketCap":3240458},{"date":"2023-12-22","current":-0.26467,"twenty":-1.893278,"median":-0.287174,"eighty":-0.179342,"marketCap":3334840},{"date":"2023-12-29","current":-0.25718,"twenty":-1.839184,"median":-0.286889,"eighty":-0.179829,"marketCap":3240458},{"date":"2024-01-05","current":-0.287142,"twenty":-1.800546,"median":-0.286002,"eighty":-0.180183,"marketCap":3617987},{"date":"2024-01-12","current":-0.352061,"twenty":-1.787667,"median":-0.286889,"eighty":-0.180403,"marketCap":4435967},{"date":"2024-01-19","current":-0.29713,"twenty":-1.777363,"median":-0.287142,"eighty":-0.180809,"marketCap":3743830},{"date":"2024-01-26","current":-0.374533,"twenty":-1.738725,"median":-0.287142,"eighty":-0.180905,"marketCap":4719114},{"date":"2024-02-02","current":-0.36954,"twenty":-1.648569,"median":-0.287174,"eighty":-0.181297,"marketCap":4656192},{"date":"2024-02-09","current":-0.294633,"twenty":-1.62281,"median":-0.290994,"eighty":-0.182747,"marketCap":3712369},{"date":"2024-02-16","current":-0.476633,"twenty":-1.609931,"median":-0.289857,"eighty":-0.182811,"marketCap":6005566},{"date":"2024-02-23","current":-0.47931,"twenty":-1.589324,"median":-0.293303,"eighty":-0.183477,"marketCap":6039299},{"date":"2024-03-01","current":-0.49934,"twenty":-1.563565,"median":-0.295134,"eighty":-0.185529,"marketCap":6291674},{"date":"2024-03-08","current":-0.420937,"twenty":-1.537806,"median":-0.29713,"eighty":-0.187269,"marketCap":5303792},{"date":"2024-03-15","current":-0.401657,"twenty":-1.522351,"median":-0.301226,"eighty":-0.187592,"marketCap":5060871},{"date":"2024-03-22","current":-0.539343,"twenty":-1.509471,"median":-0.306121,"eighty":-0.187752,"marketCap":5724083},{"date":"2024-03-28","current":-0.552464,"twenty":-1.475984,"median":-0.311621,"eighty":-0.188069,"marketCap":5863337},{"date":"2024-04-05","current":-0.582158,"twenty":-1.455377,"median":-0.312913,"eighty":-0.188946,"marketCap":6178491},{"date":"2024-04-12","current":-0.520524,"twenty":-1.44765,"median":-0.317056,"eighty":-0.189992,"marketCap":5524363},{"date":"2024-04-19","current":-0.400674,"twenty":-1.43477,"median":-0.319149,"eighty":-0.190623,"marketCap":4252385},{"date":"2024-04-26","current":-0.390727,"twenty":-1.426836,"median":-0.324381,"eighty":-0.191499,"marketCap":4146813},{"date":"2024-05-03","current":-0.406665,"twenty":-1.420036,"median":-0.328965,"eighty":-0.192296,"marketCap":4315962},{"date":"2024-05-10","current":-0.38701,"twenty":-1.416739,"median":-0.333012,"eighty":-0.192744,"marketCap":4107370},{"date":"2024-05-17","current":-0.414034,"twenty":-1.409012,"median":-0.340203,"eighty":-0.194261,"marketCap":4778658},{"date":"2024-05-24","current":-0.386958,"twenty":-1.400239,"median":-0.345309,"eighty":-0.195168,"marketCap":4466149},{"date":"2024-05-31","current":-0.38446,"twenty":-1.397663,"median":-0.35054,"eighty":-0.195327,"marketCap":4437325},{"date":"2024-06-07","current":-0.35929,"twenty":-1.394844,"median":-0.352061,"eighty":-0.195908,"marketCap":4146813},{"date":"2024-06-14","current":-0.348315,"twenty":-1.39098,"median":-0.352127,"eighty":-0.196588,"marketCap":4020141},{"date":"2024-06-21","current":-0.358489,"twenty":-1.39098,"median":-0.352127,"eighty":-0.197251,"marketCap":4137567},{"date":"2024-06-28","current":-0.352192,"twenty":-1.39098,"median":-0.352192,"eighty":-0.197427,"marketCap":4064893},{"date":"2024-07-05","current":-0.295739,"twenty":-1.39098,"median":-0.352061,"eighty":-0.197948,"marketCap":3413327},{"date":"2024-07-12","current":-0.308291,"twenty":-1.39098,"median":-0.35054,"eighty":-0.199037,"marketCap":3558204},{"date":"2024-07-15","current":-0.302639,"twenty":-1.39098,"median":-0.349428,"eighty":-0.199099,"marketCap":3492971},{"date":"2024-08-02","current":-0.303954,"twenty":-1.39098,"median":-0.348315,"eighty":-0.199161,"marketCap":3508142},{"date":"2024-08-09","current":-0.241717,"twenty":-1.387116,"median":-0.345859,"eighty":-0.199565,"marketCap":2789826},{"date":"2024-08-16","current":-0.26447,"twenty":-1.380677,"median":-0.342074,"eighty":-0.199992,"marketCap":2982489},{"date":"2024-08-23","current":-0.307981,"twenty":-1.378101,"median":-0.336589,"eighty":-0.20065,"marketCap":3473180},{"date":"2024-08-30","current":-0.307305,"twenty":-1.370373,"median":-0.334845,"eighty":-0.202073,"marketCap":3465556},{"date":"2024-09-06","current":-0.364516,"twenty":-1.360069,"median":-0.341743,"eighty":-0.202979,"marketCap":4110738},{"date":"2024-09-13","current":-0.306193,"twenty":-1.352342,"median":-0.340037,"eighty":-0.203419,"marketCap":3453020},{"date":"2024-09-20","current":-0.321066,"twenty":-1.320968,"median":-0.335355,"eighty":-0.203676,"marketCap":3620738},{"date":"2024-09-27","current":-0.26527,"twenty":-1.261837,"median":-0.332941,"eighty":-0.20384,"marketCap":2991521},{"date":"2024-10-04","current":-0.225611,"twenty":-1.240811,"median":-0.332086,"eighty":-0.204208,"marketCap":2544273},{"date":"2024-10-11","current":-0.228772,"twenty":-1.222236,"median":-0.329966,"eighty":-0.204208,"marketCap":2579914},{"date":"2024-10-18","current":-0.220531,"twenty":-1.190942,"median":-0.325844,"eighty":-0.204432,"marketCap":2486982},{"date":"2024-10-25","current":-0.387436,"twenty":-1.154623,"median":-0.327156,"eighty":-0.205107,"marketCap":4369210},{"date":"2024-10-31","current":-0.78508,"twenty":-1.119973,"median":-0.329966,"eighty":-0.206243,"marketCap":8853546},{"date":"2024-11-08","current":-0.85568,"twenty":-1.097263,"median":-0.332086,"eighty":-0.207117,"marketCap":9649713},{"date":"2024-11-15","current":-1.112489,"twenty":-1.111833,"median":-0.332941,"eighty":-0.207179,"marketCap":8817483},{"date":"2024-11-22","current":-1.463005,"twenty":-1.187197,"median":-0.335355,"eighty":-0.2074,"marketCap":11595645},{"date":"2024-11-29","current":-1.219747,"twenty":-1.20095,"median":-0.339535,"eighty":-0.207404,"marketCap":9667605},{"date":"2024-12-06","current":-1.19258,"twenty":-1.236427,"median":-0.343222,"eighty":-0.208116,"marketCap":9452284},{"date":"2024-12-13","current":-1.007606,"twenty":-1.236427,"median":-0.346409,"eighty":-0.208205,"marketCap":7986196},{"date":"2024-12-20","current":-1.3089,"twenty":-1.236427,"median":-0.348396,"eighty":-0.208854,"marketCap":10374225},{"date":"2024-12-27","current":-1.541045,"twenty":-1.25409,"median":-0.351152,"eighty":-0.20886,"marketCap":12214182},{"date":"2025-01-03","current":-1.358293,"twenty":-1.336231,"median":-0.352061,"eighty":-0.209,"marketCap":10765705},{"date":"2025-01-10","current":-1.303961,"twenty":-1.349402,"median":-0.352192,"eighty":-0.209431,"marketCap":10335077},{"date":"2025-01-17","current":-1.152491,"twenty":-1.345121,"median":-0.352708,"eighty":-0.209959,"marketCap":9134538},{"date":"2025-01-24","current":-1.307254,"twenty":-1.346768,"median":-0.358489,"eighty":-0.210043,"marketCap":10361175},{"date":"2025-01-31","current":-1.104745,"twenty":-1.338865,"median":-0.359421,"eighty":-0.21027,"marketCap":8756107},{"date":"2025-02-07","current":-1.053706,"twenty":-1.330304,"median":-0.362904,"eighty":-0.210466,"marketCap":8351577},{"date":"2025-02-14","current":-0.996081,"twenty":-1.315486,"median":-0.36403,"eighty":-0.21134,"marketCap":7894850},{"date":"2025-02-21","current":-0.926932,"twenty":-1.3089,"median":-0.364942,"eighty":-0.212244,"marketCap":7346778},{"date":"2025-02-28","current":-0.864368,"twenty":-1.307254,"median":-0.367373,"eighty":-0.212536,"marketCap":6850903},{"date":"2025-03-07","current":-0.856136,"twenty":-1.303961,"median":-0.371707,"eighty":-0.212566,"marketCap":6785656},{"date":"2025-03-14","current":-0.637359,"twenty":-1.279265,"median":-0.374533,"eighty":-0.212566,"marketCap":5090547},{"date":"2025-03-21","current":-0.626307,"twenty":-1.273906,"median":-0.375127,"eighty":-0.213521,"marketCap":5002277},{"date":"2025-03-28","current":-0.548899,"twenty":-1.249136,"median":-0.377888,"eighty":-0.213656,"marketCap":4384018},{"date":"2025-04-04","current":-0.402877,"twenty":-1.247983,"median":-0.38361,"eighty":-0.213683,"marketCap":3217756},{"date":"2025-04-11","current":-0.330747,"twenty":-1.243734,"median":-0.377888,"eighty":-0.213752,"marketCap":2641651},{"date":"2025-04-17","current":-0.330747,"twenty":-1.241359,"median":-0.377888,"eighty":-0.214536,"marketCap":2641651},{"date":"2025-04-25","current":-0.582325,"twenty":-1.237295,"median":-0.37685,"eighty":-0.214732,"marketCap":4650993},{"date":"2025-05-02","current":-0.522509,"twenty":-1.233817,"median":-0.383262,"eighty":-0.215726,"marketCap":4173247},{"date":"2025-05-09","current":-0.365932,"twenty":-1.222431,"median":-0.382514,"eighty":-0.21608,"marketCap":2922678},{"date":"2025-05-16","current":-0.441183,"twenty":-1.219747,"median":-0.383262,"eighty":-0.217023,"marketCap":3006986},{"date":"2025-05-23","current":-0.447368,"twenty":-1.206773,"median":-0.38446,"eighty":-0.217878,"marketCap":3049140},{"date":"2025-05-30","current":-0.451491,"twenty":-1.201982,"median":-0.384903,"eighty":-0.218264,"marketCap":3077243},{"date":"2025-06-06","current":-0.564674,"twenty":-1.195928,"median":-0.386958,"eighty":-0.218495,"marketCap":3848663},{"date":"2025-06-13","current":-0.516411,"twenty":-1.19104,"median":-0.388248,"eighty":-0.21863,"marketCap":3519717},{"date":"2025-06-20","current":-0.513998,"twenty":-1.188835,"median":-0.39137,"eighty":-0.218686,"marketCap":3503270},{"date":"2025-06-27","current":-0.535716,"twenty":-1.185222,"median":-0.394081,"eighty":-0.219102,"marketCap":3651296},{"date":"2025-07-03","current":-0.557434,"twenty":-1.182061,"median":-0.399017,"eighty":-0.219726,"marketCap":3799321},{"date":"2025-07-11","current":-0.504345,"twenty":-1.180151,"median":-0.399987,"eighty":-0.219813,"marketCap":3437481},{"date":"2025-07-18","current":-0.751307,"twenty":-1.178504,"median":-0.401019,"eighty":-0.22017,"marketCap":5120707},{"date":"2025-07-25","current":-0.76522,"twenty":-1.176936,"median":-0.401964,"eighty":-0.220207,"marketCap":5215535},{"date":"2025-08-01","current":-0.726959,"twenty":-1.175387,"median":-0.402877,"eighty":-0.220276,"marketCap":4954758},{"date":"2025-08-08","current":-0.723481,"twenty":-1.169069,"median":-0.405593,"eighty":-0.220392,"marketCap":4931051},{"date":"2025-08-15","current":-0.929108,"twenty":-1.150186,"median":-0.408094,"eighty":-0.220472,"marketCap":6114994},{"date":"2025-08-22","current":-0.933618,"twenty":-1.139069,"median":-0.409736,"eighty":-0.220573,"marketCap":6144679},{"date":"2025-08-29","current":-0.947149,"twenty":-1.130745,"median":-0.414034,"eighty":-0.220768,"marketCap":6233732},{"date":"2025-09-05","current":-0.9697,"twenty":-1.127795,"median":-0.418503,"eighty":-0.220875,"marketCap":6382154},{"date":"2025-09-12","current":-0.960724,"twenty":-1.122663,"median":-0.421877,"eighty":-0.221392,"marketCap":6323082},{"date":"2025-09-19","current":-0.947149,"twenty":-1.117916,"median":-0.425864,"eighty":-0.22144,"marketCap":6233732},{"date":"2025-09-26","current":-1.019312,"twenty":-1.112489,"median":-0.430234,"eighty":-0.221723,"marketCap":6708683},{"date":"2025-10-03","current":-1.105007,"twenty":-1.11133,"median":-0.434538,"eighty":-0.221973,"marketCap":7272687},{"date":"2025-10-10","current":-1.050884,"twenty":-1.11133,"median":-0.435042,"eighty":-0.224695,"marketCap":6916474},{"date":"2025-10-17","current":-1.15913,"twenty":-1.114027,"median":-0.436493,"eighty":-0.224808,"marketCap":7628901},{"date":"2025-10-24","current":-0.951659,"twenty":-1.114027,"median":-0.438675,"eighty":-0.225611,"marketCap":6263416},{"date":"2025-10-31","current":-0.97421,"twenty":-1.112489,"median":-0.441183,"eighty":-0.225647,"marketCap":6411839},{"date":"2025-11-07","current":-0.933618,"twenty":-1.11133,"median":-0.4464,"eighty":-0.225968,"marketCap":6144679},{"date":"2025-11-14","current":-0.933618,"twenty":-1.109517,"median":-0.447368,"eighty":-0.226737,"marketCap":6144679},{"date":"2025-11-21","current":-0.519612,"twenty":-1.109211,"median":-0.450935,"eighty":-0.227075,"marketCap":5701431},{"date":"2025-11-28","current":-0.571251,"twenty":-1.10856,"median":-0.452846,"eighty":-0.227389,"marketCap":6268033},{"date":"2025-12-05","current":-0.526067,"twenty":-1.105685,"median":-0.460769,"eighty":-0.227585,"marketCap":5772257},{"date":"2025-12-12","current":-0.470074,"twenty":-1.104797,"median":-0.465167,"eighty":-0.227723,"marketCap":5157875},{"date":"2025-12-19","current":-0.377383,"twenty":-1.097738,"median":-0.463108,"eighty":-0.228568,"marketCap":4140829},{"date":"2025-12-26","current":-0.367452,"twenty":-1.095986,"median":-0.455656,"eighty":-0.228845,"marketCap":4031860},{"date":"2026-01-02","current":-0.304555,"twenty":-1.094182,"median":-0.452138,"eighty":-0.228893,"marketCap":3341722},{"date":"2026-01-09","current":-0.3509,"twenty":-1.089539,"median":-0.450036,"eighty":-0.228903,"marketCap":3850245},{"date":"2026-01-16","current":-0.297934,"twenty":-1.081354,"median":-0.447139,"eighty":-0.228917,"marketCap":3269076},{"date":"2026-01-23","current":-0.294194,"twenty":-1.072533,"median":-0.445907,"eighty":-0.228952,"marketCap":3228031},{"date":"2026-01-30","current":-0.238347,"twenty":-1.067528,"median":-0.440503,"eighty":-0.229277,"marketCap":2615261},{"date":"2026-02-06","current":-0.151946,"twenty":-1.060629,"median":-0.437558,"eighty":-0.228917,"marketCap":1667228},{"date":"2026-02-13","current":-0.136719,"twenty":-1.055386,"median":-0.43596,"eighty":-0.227954,"marketCap":1500142},{"date":"2026-02-20","current":-0.132581,"twenty":-1.055352,"median":-0.435042,"eighty":-0.227075,"marketCap":1454738},{"date":"2026-02-27","current":-0.13076,"twenty":-1.054591,"median":-0.434538,"eighty":-0.225611,"marketCap":1434761},{"date":"2026-03-06","current":-0.178396,"twenty":-1.053706,"median":-0.430234,"eighty":-0.221723,"marketCap":1957450},{"date":"2026-03-13","current":-0.143671,"twenty":-1.050884,"median":-0.425864,"eighty":-0.220741,"marketCap":1576421},{"date":"2026-03-20","current":-0.190347,"twenty":-1.049469,"median":-0.421877,"eighty":-0.220251,"marketCap":2088576},{"date":"2026-03-27","current":-0.181078,"twenty":-1.04712,"median":-0.418503,"eighty":-0.219726,"marketCap":1986871},{"date":"2026-04-02","current":-0.195256,"twenty":-1.046523,"median":-0.414034,"eighty":-0.218521,"marketCap":1986871},{"date":"2026-04-10","current":-0.441293,"twenty":-1.046374,"median":-0.419505,"eighty":-0.218658,"marketCap":4490464},{"date":"2026-04-17","current":-0.464999,"twenty":-1.037751,"median":-0.422817,"eighty":-0.218686,"marketCap":4731687},{"date":"2026-04-24","current":-0.386587,"twenty":-1.031439,"median":-0.421877,"eighty":-0.219518,"marketCap":3933795},{"date":"2026-05-01","current":-0.338811,"twenty":-1.02153,"median":-0.418503,"eighty":-0.219726,"marketCap":3447637},{"date":"2026-05-08","current":-0.337352,"twenty":-1.019167,"median":-0.413916,"eighty":-0.220076,"marketCap":3432793},{"date":"2026-05-15","current":-0.25274,"twenty":-1.015668,"median":-0.410815,"eighty":-0.220189,"marketCap":2571811},{"date":"2026-05-22","current":-0.254329,"twenty":-1.014314,"median":-0.409355,"eighty":-0.22024,"marketCap":2997663},{"date":"2026-05-29","current":-0.236933,"twenty":-1.011852,"median":-0.407544,"eighty":-0.220326,"marketCap":2792623},{"date":"2026-06-05","current":-0.234729,"twenty":-1.00868,"median":-0.404521,"eighty":-0.220229,"marketCap":2766645},{"date":"2026-06-12","current":-0.207415,"twenty":-1.006512,"median":-0.402877,"eighty":-0.21931,"marketCap":2444705},{"date":"2026-06-18","current":-0.212374,"twenty":-1.005782,"median":-0.401964,"eighty":-0.218603,"marketCap":2503155},{"date":"2026-06-26","current":-0.352821,"twenty":-1.003219,"median":-0.401019,"eighty":-0.218686,"marketCap":4158541},{"date":"2026-07-02","current":-0.376135,"twenty":-1.000656,"median":-0.400947,"eighty":-0.219547,"marketCap":4433328},{"date":"2026-07-10","current":-0.345341,"twenty":-1.000656,"median":-0.400947,"eighty":-0.220351,"marketCap":4070374},{"date":"2026-07-17","current":-0.34584,"twenty":-1.000656,"median":-0.400947,"eighty":-0.220699,"marketCap":4076252},{"date":"2026-07-24","current":-0.339855,"twenty":-1.000656,"median":-0.400947,"eighty":-0.221666,"marketCap":4005718},{"date":"2026-07-31","current":-0.320406,"twenty":-1.001937,"median":-0.400983,"eighty":-0.225633,"marketCap":3776484},{"date":"2026-08-07","current":-0.653654,"twenty":-1.001937,"median":-0.401964,"eighty":-0.227556,"marketCap":7704322},{"date":"2026-08-14","current":-0.434481,"twenty":-1.001937,"median":-0.405593,"eighty":-0.228907,"marketCap":5121030},{"date":"2026-08-21","current":-0.485647,"twenty":-0.985034,"median":-0.405593,"eighty":-0.228907,"marketCap":6130756},{"date":"2026-08-28","current":-0.614965,"twenty":-0.971504,"median":-0.405593,"eighty":-0.228907,"marketCap":7763260},{"date":"2026-09-04","current":-0.678157,"twenty":-0.963836,"median":-0.405593,"eighty":-0.228907,"marketCap":8560989},{"date":"2026-09-11","current":-0.795139,"twenty":-0.960679,"median":-0.405593,"eighty":-0.228907,"marketCap":10037760},{"date":"2026-09-18","current":-0.697423,"twenty":-0.951659,"median":-0.405593,"eighty":-0.228907,"marketCap":8804199},{"date":"2026-09-25","current":-0.616661,"twenty":-0.947149,"median":-0.405593,"eighty":-0.228907,"marketCap":7784663},{"date":"2026-10-02","current":-0.616198,"twenty":-0.942638,"median":-0.405593,"eighty":-0.228907,"marketCap":7778826},{"date":"2026-10-07","current":-0.662436,"twenty":-0.938128,"median":-0.405593,"eighty":-0.228907,"marketCap":8362530}],"updateTime":1791503218896},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENSC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2646520983","title":"Ensysce Biosciences enrolls first patient in final stage of PF614-MPAR-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2646520983","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646520983?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:05","pubTimestamp":1782475515,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced initiation of the final stage of the PF614-MPAR-102 clinical study. The study is evaluating its novel MPAR ove...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-enrolls-first-patient-in-final-stage-of-pf614-mpar-102-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-enrolls-first-patient-in-final-stage-of-pf614-mpar-102-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646529193","title":"Ensysce Enrolls First Patient in Final Phase of Pf614-mpar-102 Overdose-protection Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2646529193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646529193?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:04","pubTimestamp":1782475455,"startTime":"0","endTime":"0","summary":"Ensysce enrolls first patient in final phase of PF614-MPAR-102 overdose-protection trialEnsysce Biosciences initiated the final stage of its PF614-MPAR-102 clinical study, enrolling the first patient ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL5r4trC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641316725","title":"Ensysce Biosciences Files for Sale of 1.3 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2641316725","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641316725?lang=en_us&edition=fundamental","pubTime":"2026-06-05 05:02","pubTimestamp":1780606960,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) filed a registration statement with the US Securities and Exchange Commission late Thursday for the resale of up to 1.3 million shares.The company said the selling securityholders will receive all proceeds from the offering.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641167406","title":"Ensysce Biosciences files to sell 1.3M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2641167406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641167406?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:45","pubTimestamp":1780605912,"startTime":"0","endTime":"0","summary":"16:44 EDT Ensysce Biosciences (ENSC) files to sell 1.3M shares of common stock for holders Published first on TheFly – the ultimate source for real...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-files-to-sell-1-3m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-files-to-sell-1-3m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637004344","title":"Ensysce Biosciences faces Nasdaq delisting risk over $2.5 million equity shortfall","url":"https://stock-news.laohu8.com/highlight/detail?id=2637004344","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637004344?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:55","pubTimestamp":1779483357,"startTime":"0","endTime":"0","summary":"Nasdaq issued a notice on May 21, 2026, citing non-compliance with the $2.5 million stockholders’ equity requirement under Listing Rule 5550 as of March 31, 2026.Delisting risk unless a compliance plan is submitted within 45 days, due by July 6, 2026.Acceptance of the plan could allow up to a 180-day extension from May 21, 2026, to regain compliance.Rejection would shift the process to an appeal to the Nasdaq Hearings Panel.Management plans to submit a plan on time while exploring options to restore compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL33F5lt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636600394","title":"Ensysce Biosciences posts investor presentation on trypsin-controlled opioids with abuse, overdose protection","url":"https://stock-news.laohu8.com/highlight/detail?id=2636600394","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636600394?lang=en_us&edition=fundamental","pubTime":"2026-05-19 02:13","pubTimestamp":1779128022,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences outlined a planned US pain franchise built around its trypsin-controlled TAAP platform for abuse deterrence, led by PF614, an oxycodone prodrug.The company positioned PF614 for acute severe post-surgical pain, citing a Phase 3 abdominoplasty study initiated in 2025 as the pivotal trial intended to support an NDA in 2027.A second Phase 3 study in bunionectomy was slated to start in 2026 to expand the safety database.For chronic pain, Ensysce highlighted PF614-MPAR, which combines PF614 with the trypsin inhibitor nafamostat to limit oxycodone release at higher dose-unit exposure as an overdose-mitigation approach.The pipeline also includes TAAP-based candidates in ADHD and opioid use disorder, alongside MPAR-related work in infectious and respiratory diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL6kV6cv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635053722","title":"Ensysce Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635053722","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635053722?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:07","pubTimestamp":1778882864,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc reports results for the quarter ended March 31 - Earnings SummaryEnsysce Biosciences Inc ENSC.OQ reported a quarterly adjusted loss of 52 cents per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S292:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635058352","title":"BRIEF-Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058352","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058352?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:49","pubTimestamp":1778878179,"startTime":"0","endTime":"0","summary":"BRIEF-Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC FilingMay 15  - Ensysce Biosciences Inc ENSC.O:ENSYSCE BIOSCIENCES INC - LAUNCHES FORMAL REVIEW OF STRATEGIC ALTERNATIVES - SEC FILINGSource text: [ID:n0001493152-26-023810]Further company coverage: ENSC.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S1FO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635205887","title":"Ensysce Biosciences Inc - Launches Formal Review of Strategic Alternatives - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635205887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635205887?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:48","pubTimestamp":1778878108,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S1FO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635897030","title":"Ensysce Biosciences Q1 EPS $(0.52) Beats $(0.73) Estimate, Sales $960.999K Miss $1.900M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635897030","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635897030?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:23","pubTimestamp":1778876583,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.73) by 28.77 percent. This is a 62.59 percent increase over losses of $(1.39) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52616370/ensysce-biosciences-q1-eps-0-52-beats-0-73-estimate-sales-960-999k-miss-1-900m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ensysce Biosciences Q1 EPS $(0.52) Beats $(0.73) Estimate, Sales $960.999K Miss $1.900M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635739037","title":"Ensysce Q1 FY26 net loss widens to $3.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635739037","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635739037?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:16","pubTimestamp":1778876162,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences posted a Q1 net loss attributable to common stockholders of USD 3.6 million, widening from USD 1.9 million a year earlier; loss per share narrowed to USD 0.52 from USD 1.39.R&D expense climbed to USD 3.3 million from USD 1.9 million on higher Phase 3 clinical trial activity for PF614, while G&A expense eased to USD 1.2 million from USD 1.4 million.Cash and cash equivalents fell to USD 745,482 at March 31 from USD 4.3 million at Dec. 31; net cash used in operating activities increased to USD 3.5 million from USD 1.7 million.Federal grants slipped to USD 960,999 from USD 1.32 million, while a second tranche of USD 2 million in convertible preferred stock financing closed April 7 under a facility for up to USD 20 million over 24 months.Operationally, PF614-301 Phase 3 trial reached 50% of interim enrollment target, IRB clearance secured to start Part 3 of PF614-MPAR-102, while board launched a formal review of strategic alternatives including partnerships and licensing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLcc0GK1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634245366","title":"Ensysce announces expansion of patent protection for MPAR technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2634245366","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634245366?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:40","pubTimestamp":1778600441,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced that the Taiwan Intellectual Property Office issued a patent covering Ensysce’s MPAR technology. The patent, t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-announces-expansion-of-patent-protection-for-mpar-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-announces-expansion-of-patent-protection-for-mpar-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634167212","title":"Ensysce says Taiwan grants MPAR overdose-protection patent through 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2634167212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634167212?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:01","pubTimestamp":1778587269,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences secured a Taiwan patent covering MPAR overdose-protection technology, extending jurisdictional protection through 2042.Patent includes composition-of-matter claims, method-of-use claims tied to enzyme-cleavable prodrugs, controlled-release nafamostat.Coverage expands U.S. Patent No. 12,599,578, issued April 14, 2026.MPAR holds FDA Breakthrough Therapy designation, aims to curb opioid release in overdose scenarios while maintaining pain relief when used as directed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL4JwvB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634328653","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2634328653","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634328653?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:57","pubTimestamp":1778500678,"startTime":"0","endTime":"0","summary":"Helport AI  shares were up 42% in Monday premarket activity, adding to Friday's rally.Everspin Technologies  shares were 41% higher, extending gains from the previous session.Ensysce Biosciences  stock was up 15%, recovering from Friday's loss.Intel  stock was 5.7% higher after The Wall Street Journal reported Friday that Apple  and Intel reached a preliminary agreement under which the company will make some of the chips powering Apple devices.Emerald  shares were up 11% after Apollo Global Management  said its managed funds signed definitive agreements to purchase Emerald and Questex to form a combined business events platform.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0965509010.AUD","LU1935042488.USD","LU1718418525.SGD","LU1119994496.HKD","LU1934455194.USD","IE00BLSP4452.SGD","LU2148611432.USD","LU2168564149.EUR","SG9999015952.SGD","LU0472753341.HKD","LU0724617625.USD","LU2746668461.USD","LU2471134952.CNY","LU1366192091.USD","LU2023250843.SGD","LU2100268510.USD","IE00B19Z9505.USD","SG9999015978.USD","LU1244550221.USD","LU0289961442.SGD","LU2097344431.USD","LU2237443895.HKD","LU2461242641.AUD","IE00BJLML261.HKD","SG9999014567.USD","IE000W1ABFV2.USD","LU0265550946.USD","IE00B775H168.HKD","LU0053666078.USD","AAPD","LU0795875169.SGD","LU2552382132.HKD","IE00BN8TJ469.HKD","LU1989772923.USD","APO","LU2347655156.SGD","LU2168564065.EUR","BK4553","LU0795875086.SGD","LU2462157665.USD","LU1989771016.USD","LU1629891620.HKD","IE00BZ1G4Q59.USD","LU2471134879.HKD","LU0289739343.SGD","SG9999015945.SGD","BK4515","SG9999017495.SGD","LU0444971666.USD","LU2552382215.SGD","MRAM","LU0265550359.USD","BK4141","BK4170","LU2271345857.HKD","LU2089284900.SGD","LU2250418816.HKD","LU0868494617.USD","LU2458330169.SGD","LU1642822529.SGD","LU1116320901.HKD","AAPL","IE00BDRTCR15.USD","LU1674673691.USD","LU2471134796.USD","INTW","IE00BLSP4239.USD","LU0868494708.USD","LU1037948541.HKD","LU1206712785.SGD","LU0234572021.USD","LU0072462426.USD","BK4571","IE00BYXW3230.USD","LU0267386448.USD","IE0004091025.USD","LU0079474960.USD","LU0726765562.USD","LU2756315664.SGD","LU1244550577.SGD","LU2023250330.USD","LU2237443622.USD","BK4135","LU0787776722.HKD","BK4574","LU2417539215.USD","LU0061474960.USD","LU2361044949.HKD","LU1868836591.USD","LU1145028129.USD","LU1571399168.USD","BK4559","LU0210536198.USD","AAPW","LU0143551892.USD","LU0348723411.USD","IE000F7OJYX1.SGD","LU0417517546.SGD","LU0820562030.AUD","SG9999014575.USD","HPAI","IE00BK4W5L77.USD","LU2106854487.HKD","LU1291159041.SGD","LU0823434740.USD","LU1868836757.USD","LU0234570918.USD","LU0154236417.USD","LU0353189680.USD","LU0057025933.USD","LU0784384876.USD","LU2168564222.USD","LU1989764748.USD","LU0985320562.USD","LU2213496289.HKD","LU2360032135.SGD","HK0000532082.HKD","LU0149725797.USD","BK4566","LU1934455863.HKD","LU1732799900.SGD","BK4529","LU2237438978.USD","LU1582986359.USD","LU2381873111.SGD","SG9999014559.SGD","LU0738911758.USD","BK4501","LU0323591593.USD","BK4585","LU2592432038.USD","LU0077335932.USD","LU1582987324.SGD","LU0345768740.USD","LU2543165471.USD","LU1868836914.USD","LU2089985449.USD","LU1914381329.SGD","LU0345770308.USD","IE00B1XK9C88.USD","LU2077746001.SGD","LU1852331112.SGD","IE000M9KFDE8.USD","LU0784385840.USD","SG9999015341.SGD","LU1839511570.USD","LU0354030511.USD","BK4533","IE00BFSS8Q28.SGD","LU0274383776.USD","LU1551013425.SGD","LU0097036916.USD","LU1815333072.USD","LU2487616109.SGD","LU1989764664.SGD","IE00BWXC8680.SGD","BK4605","LU0965509283.SGD","LU1301847155.USD","LU0444973449.USD","LU1261432733.SGD","LU0256863902.USD","LU1323610961.USD","IE0003U64NQ7.SGD","LU2111349929.HKD","LU1791710582.SGD","LU0823421333.USD","LU2552382058.USD","LU2247934214.USD","LU1235294995.USD","LU2133065610.SGD","ENSC","IE00BJTD4V19.USD","LU0965508806.USD","IE00B4JS1V06.HKD","LU0109392836.USD","LU2191332357.HKD","LU1244550494.USD","LU0511384066.AUD","LU1116320737.USD","LU1127390331.HKD","BK4581","IE00B19Z8X17.USD","SG9999014906.USD","LU0882574139.USD","LU2028103732.USD","LU2456880835.USD","IE00BBT3K403.USD","LU0820561909.HKD","LU1232071149.USD","LU0528227936.USD","LU1988902786.USD","LU2236285917.USD","LU2430703095.HKD","LU0719512351.SGD","LU1496350502.SGD","LU2047632596.USD","LU0069063385.USD","LU2420271590.USD","LU1935042991.SGD","IE0034235303.USD","MACW.SI","LU0238689110.USD","LU2265009873.SGD","IE00BFSS7M15.SGD","LU0096362180.USD","IE00B4YYXB79.USD","SG9999014898.SGD","LU2065171402.SGD","HK0000320264.USD","LU0316494557.USD","LU0949170426.SGD","LU1699723380.USD","LU0314106906.USD","LU2054465674.USD","LU0215105999.USD","BK4575","LU0786609619.USD","BK4602","LU0965509101.SGD","IE0004086264.USD","BK4184","LU0942090050.USD","GB00BDT5M118.USD","SG9999018857.SGD","LU1823568750.SGD","LU2462591277.SGD","IE0001KFT4U8.USD","BK4573","LU0949170772.SGD","EEX","AAPY","LU0820561818.USD","LU0553294199.USD","BK4512","HK0000306701.USD","LU2237443465.HKD","LU0011850046.USD","BK4598","IE000SO60NU8.SGD","IE000WAW04H5.SGD","APLY","LU0689472784.USD","IE0000B7K699.USD","BK4507","LU0082616367.USD","IE00B3SWFQ91.USD","BK4550","INTC","LU0096364046.USD","LU2023250504.SGD","IE00BKVL7J92.USD","LU0957791311.USD","LU2065169927.USD","LU2097344357.USD","HK0000306685.HKD","IE00B7KXQ091.USD","LU0198837287.USD","LU0545039389.USD","LU0788109477.HKD","LU1267930730.SGD","LU2237443978.SGD","LU1066051811.HKD","LU0353189763.USD","BK4612","LU1803068979.SGD","LU0912757837.SGD","LU0308772762.SGD","LU0784383803.USD","LU2347655073.USD","LU3102509885.SGD","LU2286300806.USD","LU0158827948.USD","LU1935042215.USD","IE00BDCRKT87.USD","BK4592","LU0124676726.USD","LU1934455277.USD","BK4023","LU0964807845.USD","LU0823421416.USD","LU1814569148.SGD","LU1791710400.SGD","IE00BJJMRX11.SGD","LU2168564495.EUR","LU2168563687.JPY","04335","LU2237443549.SGD","SGXZ31699556.SGD","LU0957808578.USD","LU0314104364.USD","SG9999000418.SGD","LU2954938101.SGD","LU0081259029.USD","LU0345769128.USD","LU1582986433.USD","LU1778281490.HKD","LU1316542783.SGD","LU0106831901.USD","LU0056508442.USD","LU0784385170.HKD","LU1674673428.USD","LU2746668974.SGD","SG9999018865.SGD","LU0256863811.USD","BK4543","LU1084165304.USD","LU2089283258.USD","IE0009G5SDU7.USD","IE0009356076.USD","LU0061475181.USD","LU2756315318.SGD","LU2237443382.USD","LU1868837300.USD","IE000YTNTUN2.SGD","LU0321505439.SGD","AAPX","LU0476273544.USD","BK4588","LU1046421795.USD","IE0005OL40V9.USD","LU0048584097.USD","LU2462591350.SGD","IE00B1BXHZ80.USD","LU1732800096.USD","IE00B5949003.HKD","LU1935043023.USD","LU1366333091.USD","AAPB","LU1791807156.HKD","LU1917777945.USD","HK0000819398.USD","LU0070217475.USD","LU0210528500.USD","LU1506573853.SGD","LU0006061336.USD","LU2357305700.SGD","LU2023251221.USD","LU2750360997.AUD","LU1815336760.USD","LU1066053197.SGD","HK0000320223.HKD","LU2087621335.USD","LU2108987350.USD","LU1974910355.USD","LU2430703251.USD","IE00B19Z8W00.USD","LU1037948897.HKD","LU0210533765.USD","LU2065170008.USD","LU0557290698.USD","LU1551013342.USD","LU1804176565.USD","LU0466842654.USD","LU2505996509.AUD","LU0127658192.USD","SG9999002232.USD","LINT","LU0683600562.USD","LU2505996681.GBP","LU1496350171.SGD","LU0170899867.USD","AAPU","LU0133085943.USD","LU0640476718.USD","IE0004445015.USD","LU1868837136.USD","LU1064131342.USD","BK4505","SG9999015358.SGD","BK4576","LU0345770993.USD","LU0080751232.USD","LU1066051498.USD","LU2361044865.SGD","IE000MB6IJN5.SGD","LU1066051225.USD","LU2092627202.USD","LU0708995401.HKD","LU0661504455.SGD","LU0456855351.SGD","SG9999014880.SGD","LU2999663052.SGD","SG9999014542.SGD","BK4535","HK0000914686.HKD","LU2452424414.USD","LU2092937148.SGD","BK4554","IE000ITXATA3.USD","LU0345769631.USD","LU2931357623.SGD","SG9999002224.SGD","LU1582987597.SGD","SG9999014914.USD","LU1720051108.HKD","HK0000914660.USD","LU0203202063.USD","IE00B19Z3B42.SGD","LU0345768153.USD","BK4139","LU2063271972.USD","LU0158827781.USD","IE00BK4W5M84.HKD","LU1242518857.USD","LU0174119429.USD","LU2242650005.HKD","LU0203201768.USD","LU2750360641.GBP","LU2896262040.SGD","SG9999001424.SGD","BK4527","LU0157215616.USD","LU2602419157.SGD","LU0321505868.SGD","LU2458330243.SGD","LU0494093205.USD","LU2242649171.HKD","LU2264538146.SGD","LU1003077747.HKD","LU0354030438.USD","BK4534","IE00BN29S564.USD","IE000KEQY171.SGD","LU1280957306.USD","IE00B19Z3581.USD","BK4532","LU0251132253.USD","LU0109391861.USD","LU0889565833.HKD","LU2430703178.SGD","LU1548497426.USD","LU2361045086.USD","LU2471134523.USD","LU2125154778.USD","LU0320765059.SGD","IE00BJTD4N35.SGD","BK4579","IE0004445239.USD","IE0034235295.USD","IE00B775SV38.USD","LU1242518931.SGD","LU2637965513.SGD","LU2083900584.USD","LU2403377893.USD","LU2065171311.SGD","LU0689626769.HKD","IE00BSNM7G36.USD","LU2125154935.USD","LU1720051017.SGD","BK4009","IE00B3S45H60.SGD","LU0672654240.SGD","IE00BJJMRY28.SGD","LU1069344957.HKD","IE0002270589.USD","IE00BKDWB100.SGD","LU2860962120.EUR","LU2360106780.USD","LU0979878070.USD","LU2087625088.SGD","LU1935043536.SGD","LU0642271901.SGD","SG9999015986.USD","LU1206713676.USD","LU1668664300.SGD","LU0823434583.USD","LU1035775433.USD","LU1989772840.SGD","IE000BZT7R73.USD","LU0861579265.USD","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467105","title":"Ensysce Biosciences Inc  expected to post a loss of 73 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467105","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467105?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:15","pubTimestamp":1778274919,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc  expected to post a loss of73cents a share - Earnings Preview Ensysce Biosciences Inc ENSC.OQ ENSC.O is expected to  show a rise in quarterly revenue when it reports  results o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2OC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455958","title":"Ensysce CEO speaks at Pain Therapeutics Summit Europe in Amsterdam","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455958?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241646,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences attended Pain Therapeutics Summit Europe in Amsterdam on May 7-8, 2026.CEO Lynn Kirkpatrick presented on chemically engineered opioids with built-in safety controls, highlighting TAAP and MPAR platforms, then joined a panel on safer analgesics without sacrificing efficacy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL4m7tz8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629778641","title":"Ensysce Biosciences posts investor presentation on TAAP, MPAR opioid pain programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2629778641","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629778641?lang=en_us&edition=fundamental","pubTime":"2026-04-21 02:14","pubTimestamp":1776708847,"startTime":"0","endTime":"0","summary":"Ensysce outlined commercialization strategy centered on TAAP and MPAR platforms designed to provide abuse deterrence and overdose protection using trypsin-controlled activation.Lead candidate PF614 targets acute severe pain with Phase 3 program underway, including PF614-301 initiated in 2025.Company plans to initiate PF614-302 open-label bunionectomy study in 2026 to expand safety database supporting PF614 NDA targeted for 2027.PF614-MPAR, combination of PF614 with trypsin inhibitor nafamostat, is positioned for chronic pain with Phase 1 data presented as demonstrating overdose protection.Pipeline update highlighted FDA Fast Track designation for PF614 granted in January 2018, followed by FDA Breakthrough Therapy designation for TAAP oxycodone combination product granted in January 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL7yR0Xx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627215766","title":"Ensysce secures IRB approval of final phase of PF614-MPAR-102 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2627215766","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627215766?lang=en_us&edition=fundamental","pubTime":"2026-04-16 21:08","pubTimestamp":1776344910,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced Investigational Review Board approval to initiate Part 3 of the PF614-MPAR-102 clinical study, marking the fin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-secures-irb-approval-of-final-phase-of-pf614-mpar-102-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-secures-irb-approval-of-final-phase-of-pf614-mpar-102-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627203290","title":"Ensysce gets IRB clearance to start final phase of PF614-MPAR-102 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2627203290","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627203290?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:09","pubTimestamp":1776341375,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences initiated final stage of PF614-MPAR-102 clinical study following IRB clearance.Previously published clinical data were already presented, showing PF614-MPAR maintained intended opioid exposure under prescribed use.Those results also indicated overdose-protection behavior, limiting additional opioid release when excessive oral doses were taken.Part 3 will be presented in future readouts, aiming to confirm protective effect across multiple dosing scenarios.Program supports Ensysce strategy to differentiate PF614-MPAR as a next-generation opioid with built-in oral overdose protection, extending MPAR platform toward other CNS categories.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLbYq9gZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626750183","title":"Ensysce Biosciences files to sell 20.34M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2626750183","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626750183?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:12","pubTimestamp":1775729571,"startTime":"0","endTime":"0","summary":"06:05 EDT Ensysce Biosciences (ENSC) files to sell 20.34M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-files-to-sell-20-34m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-files-to-sell-20-34m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}